When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

Dermatomyositis

Última revisión: 1 Dec 2025
Última actualización: 19 Mar 2024

Resumen

Definición

Anamnesis y examen

Principales factores de diagnóstico

  • Gottron papules
  • heliotrope rash with or without periorbital edema
  • macular violaceous erythema
  • periungual erythema, nail-fold capillary dilation, cuticular overgrowth
  • "mechanic's" hands
  • proximal muscle weakness
Todos los datos

Otros factores de diagnóstico

  • photosensitivity
  • poikiloderma vasculare atrophicans
  • pruritus
  • fatigue and malaise
  • dyspnea
  • weight loss
  • fever
  • myalgia
  • arthralgia
  • dysphagia
  • palpitations and syncope
  • Raynaud phenomenon
  • cutaneous calcinosis
  • erythroderma
  • vesiculobullous lesions
  • leukocytoclastic vasculitis
  • cutaneous necrosis
  • nonscarring alopecia
Todos los datos

Factores de riesgo

  • genetic predisposition
  • bimodal age distribution: children and age >40 years
  • female sex
  • black race
  • ultraviolet radiation
  • infectious agents
  • drugs
  • immunization
Todos los datos

Pruebas diagnósticas

Primeras pruebas diagnósticas para solicitar

  • serum creatine kinase (CK)
  • serum aldolase
  • muscle biopsy
  • electromyogram (EMG)
  • skin biopsy
  • antinuclear antibody (ANA)
  • myositis-specific antibodies (MSAs) and myositis-associated antibodies (MAAs)
Todos los datos

Pruebas diagnósticas que deben considerarse

  • muscle MRI
  • ECG
  • echocardiography
  • cardiac troponin I
  • chest x-ray (CXR)
  • pulmonary function tests (PFTs)
  • high-resolution CT of chest
  • barium swallow or videofluoroscopic assessment of swallow
Todos los datos

Algoritmo de tratamiento

Agudo

severe disease or acute flares

En curso

combined muscle and skin disease

skin disease only

Colaboradores

Autores

Michael Edward Farrugia, MD, PgDip, MRCP (Derm)

Dermatology Specialty Trainee

Lauriston Building

NHS Lothian

Edinburgh

UK

Divulgaciones

MEF has received funding from AbbVie to attend an international dermatology conference.

Meng May Chee, MBChB, MD, MRCP

Consultant Rheumatologist

Queen Elizabeth University Hospital

Glasgow

UK

Divulgaciones

MMC accepted a sponsored invitation to attend the EULAR e-congress in June 2020.

Girish Gupta, FRCP

Consultant Dermatologist

Lauriston Building

Edinburgh

UK

Divulgaciones

GG has received honoraria for membership of advisory boards from Almirall, Leo, Lilly, Mylan, and Novartis. GG has also received lecture fees from AbbVie, Almirall, Galderma, La Roche Posay, Leo, Mylan, and Novartis. GG declares that none of the payments are related to this topic or treatments discussed in this topic, and there are no contractual agreements to disseminate product information.

Agradecimientos

Dr Michael E. Farrugia, Dr Meng May Chee, and Dr Girish Gupta would like to gratefully acknowledge Dr Sarah A. Saunders, Dr Rajan Madhok, and Dr Nicola Alcorn, previous contributors to this topic.

Divulgaciones

SAS and NA declare that they have no competing interests. RM declared holding shares in GSK to the value less than £12,000.

Revisores por pares

Nizar Souayah, MD

Assistant Professor of Neurology

Director of EMG Laboratory & Peripheral Neuropathy Center

Department of Neurology & Neurosciences

New Jersey Medical School

Newark

NJ

Divulgaciones

NS declares that he has no competing interests.

Sami Khella, MD

Physician

Department of Neurology

Penn Presbyterian Medical Center

University of Pennsylvania Health System

Philadelphia

PA

Divulgaciones

SK declares that he has no competing interests.

Yusuf Yazici, MD

Assistant Professor

Associate Director

Arthritis Program

Director

Behcet's Syndrome Center

Seligman Center for Advanced Therapeutics

New York University Hospital for Joint Diseases

New York

NY

Divulgaciones

YY has served as a consultant for Bristol-Myers Squibb, Roche, Celgene, Centocor, and UCB, and has been a speaker for Pfizer and Bristol-Myers Squibb.

Agradecimiento de los revisores por pares

Los temas de BMJ Best Practice se actualizan de forma continua de acuerdo con los desarrollos en la evidencia y en las guías. Los revisores por pares listados aquí han revisado el contenido al menos una vez durante la historia del tema.

Divulgaciones

Las afiliaciones y divulgaciones de los revisores por pares se refieren al momento de la revisión.

Referencias

Nuestros equipos internos de evidencia y editoriales colaboran con colaboradores expertos internacionales y revisores pares para garantizar que brindemos acceso a la información más clínicamente relevante posible.

Artículos principales

Gerami P, Schope JM, McDonald L, et al. A systematic review of adult-onset clinically amyopathic dermatomyositis (dermatomyositis sine myositis): a missing link within the spectrum of idiopathic inflammatory myopathies. J Am Acad Dermatol. 2006 Apr;54(4):597-613. Resumen

Dalakas MC, Hohlfeld R. Polymyositis and dermatomyositis. Lancet. 2003 Sep 20;362(9388):971-82. Resumen

DeWane ME, Waldman R, Lu J. Dermatomyositis: clinical features and pathogenesis. J Am Acad Dermatol. 2020 Feb;82(2):267-81. Resumen

Artículos de referencia

Una lista completa de las fuentes a las que se hace referencia en este tema está disponible para los usuarios con acceso a todo BMJ Best Practice.
  • Dermatomyositis images
  • Diferenciales

    • Subacute cutaneous lupus erythematosus (SCLE)
    • Psoriasis
    • Cutaneous T-cell lymphoma
    Más Diferenciales
  • Guías de práctica clínica

    • 2023 American College of Rheumatology (ACR) guideline for the screening and monitoring of interstitial lung disease in people with systemic autoimmune rheumatic disease
    • 2023 American College of Rheumatology (ACR) guideline for the treatment of interstitial lung disease in people with systemic autoimmune rheumatic disease
    Más Guías de práctica clínica
  • padlock-lockedInicie sesión o suscríbase para acceder a todo el BMJ Best Practice

El uso de este contenido está sujeto a nuestra cláusula de exención de responsabilidad